CRBU
Caribou Biosciences Inc

2,717
Mkt Cap
$180.71M
Volume
6,056.00
52W High
$3.54
52W Low
$0.66
PE Ratio
-1.18
CRBU Fundamentals
Price
$1.87
Prev Close
$1.97
Open
$1.96
50D MA
$1.70
Beta
1.86
Avg. Volume
1.56M
EPS (Annual)
-$1.59
P/B
1.46
Rev/Employee
$115,041.24
$36.38
Loading...
Loading...
News
all
press releases
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
Here is how CareCloud, Inc. (CCLD) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.
Zacks·7d ago
News Placeholder
More News
News Placeholder
Caribou Biosciences Teases vispa-cel Phase 3 LBCL Plan, Eyes Financing at Leerink Conference
Executives from Caribou Biosciences (NASDAQ:CRBU) outlined upcoming clinical, regulatory, and financing milestones for its allogeneic cell therapy pipeline during a discussion at the Leerink Global...
MarketBeat·9d ago
News Placeholder
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences (CRBU) delivered earnings and revenue surprises of +14.11% and +56.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·18d ago
News Placeholder
Caribou Biosciences (NASDAQ:CRBU) Posts Earnings Results, Beats Estimates By $0.05 EPS
Caribou Biosciences (NASDAQ:CRBU - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.28) earnings per share for the quarter, beating analysts' consensus...
MarketBeat·18d ago
News Placeholder
EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates
EyePoint (EYPT) delivered earnings and revenue surprises of -3.85% and +15.89%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19d ago
News Placeholder
Urogen Pharma (URGN) Reports Q4 Loss, Beats Revenue Estimates
Urogen Pharma (URGN) delivered earnings and revenue surprises of +18.18% and +6.42%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
Caribou Biosciences (CRBU) to Release Earnings on Monday
Caribou Biosciences (NASDAQ:CRBU) will be releasing its Q4 2025 earnings before the market opens on Monday, March 9. (View Earnings Report at...
MarketBeat·21d ago
News Placeholder
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Syndax (SNDX) delivered earnings and revenue surprises of -21.88% and +10.21%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·25d ago
News Placeholder
Caribou Biosciences (NASDAQ:CRBU) Insider Sells $13,598.48 in Stock
Caribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) insider Ruhi Ahmad Khan sold 6,938 shares of the stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price...
MarketBeat·26d ago
News Placeholder
Insider Selling: Caribou Biosciences (NASDAQ:CRBU) Insider Sells 6,938 Shares of Stock
Caribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) insider Barbara Mcclung sold 6,938 shares of the firm's stock in a transaction that occurred on Tuesday, February 24th. The stock was sold at...
MarketBeat·26d ago
<
1
2
...
>

Latest CRBU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.